Beyond Air (NASDAQ:XAIR) Given Buy Rating at D. Boral Capital

D. Boral Capital restated their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a research report sent to investors on Friday,Benzinga reports. They currently have a $10.00 price target on the stock.

A number of other research firms have also issued reports on XAIR. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a report on Monday, December 22nd. Rodman & Renshaw began coverage on shares of Beyond Air in a research note on Tuesday, January 20th. They set a “buy” rating on the stock. Finally, Wall Street Zen raised shares of Beyond Air to a “sell” rating in a research note on Saturday, March 7th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $10.00.

Beyond Air Stock Up 4.7%

XAIR stock opened at $0.72 on Friday. The company has a debt-to-equity ratio of 2.65, a current ratio of 5.12 and a quick ratio of 4.77. Beyond Air has a 12 month low of $0.67 and a 12 month high of $5.84. The firm has a market capitalization of $7.61 million, a PE ratio of -0.13 and a beta of 0.41. The company’s 50 day simple moving average is $1.05 and its 200-day simple moving average is $1.47.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Friday, February 13th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.31). The company had revenue of $2.19 million during the quarter, compared to analysts’ expectations of $2.15 million. Beyond Air had a negative net margin of 447.75% and a negative return on equity of 268.82%. Equities analysts expect that Beyond Air will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Beyond Air

Large investors have recently added to or reduced their stakes in the stock. Alpine Global Management LLC acquired a new position in shares of Beyond Air during the third quarter worth about $25,000. Osaic Holdings Inc. raised its holdings in shares of Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after buying an additional 34,000 shares during the period. Virtu Financial LLC purchased a new stake in shares of Beyond Air during the 3rd quarter valued at about $48,000. Geode Capital Management LLC lifted its position in Beyond Air by 57.5% during the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock worth $49,000 after acquiring an additional 24,695 shares in the last quarter. Finally, Alyeska Investment Group L.P. purchased a new position in Beyond Air in the 3rd quarter worth approximately $1,753,000. 31.50% of the stock is currently owned by institutional investors and hedge funds.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.